Miranda An
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Miranda An has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Joseph F. Arboleda Velasquez
Harvard Medical School
3 shared publications - Leo A. Kim
Schepens Eye Research Institute of Massachusetts Eye and Ear Infirmary
3 shared publications Santiago Delgado-Tirado
Schepens Eye Research Institute, Massachusetts Eye and Ear, Boston, Massachusetts
3 shared publications- Dhanesh Amarnani
Department of Ophthalmology at Harvard Medical School Schepens Eye Research Institute of Mass Eye and Ear 20 Staniford Street 02114 02114 Boston Boston Massachusetts MA USA USA
2 shared publications - Hannah A.B. Whitmore
Schepens Eye Res Inst Mass Eye & Ear, 20 Stanford St, Boston, MA 02114 USA
2 shared publications - Jose Maria Ruiz-Moreno
Department of Ophthalmology, Puerta de Hierro-Majadahonda University Hospital, 28222 Madrid, Spain
2 shared publications
Latest Publications
- Open Access
- 1 August 2024
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 29 (08) , 086002-14
Multimodal optical imaging of the oculofacial region using a solid tissue-simulating facial phantom
Periocular inflammatory and infiltrative conditions are of particular importance given the proximity to the eye, thereby raising the risk for dry eyes, exposure keratopathy, eyelid malposition, blurry vision, eye pain, vision loss, double vision, and rarely, extension to the central nervous system. Diseases that affect the region include thyroid eye disease, rosacea, and eczema, as well as basal cell carcinoma, squamous cell carcinoma, melanoma, and vascular malformations. Clinical diagnosis and management of these diseases are oftentimes dependent on invasive, time-intensive, and costly procedures and testing, as well as immunotherapy, surgical resection, and periocular reconstruction. Non-invasive objective approaches to measuring local inflammation and infiltration are therefore needed to better quantify disease activity, progression, and treatment response.
- 1 August 2024
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 29 (08) , 086002-14
Open AccessMultimodal optical imaging of the oculofacial region using a solid tissue-simulating facial phantom
Periocular inflammatory and infiltrative conditions are of particular importance given the proximity to the eye, thereby raising the risk for dry eyes, exposure keratopathy, eyelid malposition, blurry vision, eye pain, vision loss, double vision, and rarely, extension to the central nervous system. Diseases that affect the region include thyroid eye disease, rosacea, and eczema, as well as basal cell carcinoma, squamous cell carcinoma, melanoma, and vascular malformations. Clinical diagnosis and management of these diseases are oftentimes dependent on invasive, time-intensive, and costly procedures and testing, as well as immunotherapy, surgical resection, and periocular reconstruction. Non-invasive objective approaches to measuring local inflammation and infiltration are therefore needed to better quantify disease activity, progression, and treatment response.
- Open Access
- 20 April 2022
- Published by Elsevier in Ophthalmology Science
- Vol. 2 (3)
Topical Nanoemulsion of a Runt-related Transcription Factor 1 Inhibitor for the Treatment of Pathologic Ocular Angiogenesis
- 20 April 2022
- Published by Elsevier in Ophthalmology Science
- Vol. 2 (3)
Open AccessTopical Nanoemulsion of a Runt-related Transcription Factor 1 Inhibitor for the Treatment of Pathologic Ocular Angiogenesis
- 1 July 2021
- Published by Elsevier in The American Journal of Pathology
- Vol. 191 (7) , 1193-1208
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators
- 1 July 2021
- Published by Elsevier in The American Journal of Pathology
- Vol. 191 (7) , 1193-1208
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators
- 17 December 2020
- Published by Elsevier in The American Journal of Pathology
- Vol. 191 (3) , 418-424
Treatment of Experimental Choroidal Neovascularization via RUNX1 Inhibition
- 17 December 2020
- Published by Elsevier in The American Journal of Pathology
- Vol. 191 (3) , 418-424
Treatment of Experimental Choroidal Neovascularization via RUNX1 Inhibition